First Financial Bank Trust Division Has $259,000 Position in UnitedHealth Group Incorporated $UNH

Key Points

• First Financial Bank Trust Division has reduced its stake in UnitedHealth Group by 52.9%, owning 830 shares worth $259,000 after selling 934 shares in the second quarter.
• UnitedHealth Group reported an EPS of $4.08 for the latest quarter, missing the analysts' estimates by $0.37 despite a revenue of $111.62 billion.
• The company recently announced a quarterly dividend of $2.21 per share, representing a yield of 2.5% and an annualized dividend of $8.84.

First Financial Bank Trust Division decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 52.9% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 830 shares of the healthcare conglomerate's stock after selling 934 shares during the quarter. First Financial Bank Trust Division's holdings in UnitedHealth Group were worth $259,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Bayforest Capital Ltd raised its stake in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd raised its stake in UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after purchasing an additional 50 shares in the last quarter. IAG Wealth Partners LLC acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at approximately $42,000. Copia Wealth Management acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $42,000. Finally, O Brien Wealth Partners LLC raised its position in shares of UnitedHealth Group by 74.0% in the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after buying an additional 37 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Trading Down 0.3%

UNH traded down $1.00 during trading on Friday, reaching $352.61. 13,985,550 shares of the company's stock were exchanged, compared to its average volume of 16,174,808. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $319.35 billion, a PE ratio of 15.28, a price-to-earnings-growth ratio of 2.30 and a beta of 0.44. The firm has a fifty day moving average price of $291.98 and a two-hundred day moving average price of $368.31.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the previous year, the firm earned $6.80 earnings per share. The company's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's dividend payout ratio is currently 38.30%.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on UNH. Bank of America boosted their target price on shares of UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a research report on Monday, August 18th. Barclays boosted their target price on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a research report on Thursday, September 4th. Robert W. Baird reaffirmed an "underperform" rating and set a $198.00 price target (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a report on Friday. Finally, Piper Sandler decreased their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.